1 / 52

Physiological basis of the care of the elderly client

Physiological basis of the care of the elderly client. Respiratory System. Patient Scenario. D.A. is a 78 year old male who states he cannot get rid of his “cold” He has a productive cough Sputum is white to grey He has a 31 pack year smoking history

lorene
Download Presentation

Physiological basis of the care of the elderly client

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Physiological basis of the care of the elderly client Respiratory System

  2. Patient Scenario • D.A. is a 78 year old male who states he cannot get rid of his “cold” • He has a productive cough • Sputum is white to grey • He has a 31 pack year smoking history • He uses Albuterol inhaler up to 6 times per day

  3. Informal evaluation What additional information do you need? • Subjective information • Objective information • Psychosocial information

  4. Anatomy of the lungs

  5. Performance of respiration • Controlled by respiratory muscles of the thorax • Diaphragm • Intercostal muscles • Coordinated by respiratory centers of the brain and carotid arteries • Respiratory centers respond to changes in: • Blood levels of oxygen • Carbon dioxide • Blood pH

  6. Age related changes of the respiratory system • Stiffening of connective tissue of lungs • Alteration in alveolar shape → increased alveolar diameter • Decreased alveolar surface area • Increased chest wall stiffness • Stiffening of the diaphragm

  7. Consequences of age-related changes • Increased residual volume • Decreased vital capacity • Premature airway closure → air trapping in lower airways

  8. Abnormal breath sounds • Crackles—intermittent, nonmusical, caused by fluid filled alveoli popping open • Wheezes—high pitched, occur when air flow is blocked • Rhonchi—low pitched, snoring, rattling, occur when fluid partially blocks large airways

  9. Measurement of oxygenation

  10. Lung volumes and capacities

  11. PFT results are based on predicted values

  12. Arterial blood gases

  13. Overlapping symptoms • Pulmonary embolism? • GERD? • Obstruction? • ACEi cough? • Vocal cord dysfunction?

  14. Commonalities within lung diseases

  15. Asthma • Airway inflammation • Increased mucous secretion production • Increased airway responsiveness/sensitivity • Reversible airflow obstruction (usually) • Eventually causes irreversible damage and scarring • Often overlooked in the older client

  16. The asthmatic lung

  17. Symptoms of asthma • Coughing • Wheezing • Shortness of breath • Chest tightness • Nocturnal dyspnea between 0400-0600 • CHF nocturnal dyspnea occurs 1-2 hours after retiring

  18. Classifications of asthma

  19. Goals of asthma therapy • Prevent symptoms that interfere with quality of life • Prevent exacerbations of asthma • Minimize need for emergency department visits • Maintain normal activity levels • Maintain (nearly) normal pulmonary function • Minimize use of “rescue” medication • Minimize adverse effects of medication

  20. Stepwise approach to managing asthma Intermittent asthma • Step 1 • Preferred: short acting β-agonist (SABA) prn • Example: Albuterol Persistent asthma with daily medication • Step 2 • Preferred: low dose inhaled corticosteroids (ICS) • Example: Beclomethasone

  21. Stepwise approach to managing asthma • Step 3 • Preferred: Low dose ICS + LABA or medium dose ICS • Example LABA: Advair • Step 4 • Preferred: Medium dose ICS + LABA

  22. Stepwise approach to managing asthma • Step 5 • Preferred: High dose ICS + LABA • And consider Omalizumab for patients who have allergies • Step 6 • Preferred: High dose ICS + LABA + oral corticosteroid • And consider Omalizumab for patients who have allergies

  23. Stepwise approach to managing asthma • At each step… • Patient education • Environmental control • Step up if needed • Step down if possible and if asthma is well controlled for at least 3 months

  24. Use of inhalers • Refer to video link in syllabus • Spacers are useful for the elderly who have difficulty with coordination and timing (refer to link) • Encourage to rinse with warm water and expectorate (“swish and spit ”) to minimize candidiasis, gum disease, tooth decay

  25. Use of nebulizers • Provides misted form of medication • Easy to use at home • Machine requires regular cleaning • Breathe slowly, deeply • Hold each breath 1-2 seconds before breathing out • Important to continue until dose is complete

  26. Use of peak flow meter • Measures movement of air out of lungs • Helps patient antici- pate asthmatic episode • Patient finds best peak flow number • Every day for 2 weeks • On waking and between 1200-1400 • Before inhaled β-agonist

  27. Potentially harmful medications for the patient with asthma • Β-blockers—can induce bronchospasm • NSAIDs—bronchospasm • Diuretics—hypokalemia • Antihistamines—prolonged QT interval • ACEi—cough • Antidepressants—symptoms of depression can be worsened by corticosteroids

  28. Chronic obstructive pulmonary disease

  29. Criteria for chronic bronchitis • Cough and sputum production on most days • Minimum of 3 months for at least 2 successive years, or, • For 6 months during 1 year

  30. A note on acute bronchitis… • Acute inflammation of the bronchi • Usually self-limiting • Viral • Similar to pneumonia: productive cough, chills, lethargy, low grade fever • Negative chest xray • Treatment: rest, humidification, cough suppressants, acetaminophen

  31. Criteria for emphysema • Permanent destruction of the alveoli • Collapse/narrowing of bronchioles • Usually in older adults with long smoking history

  32. Chronic bronchitis Emphysema

  33. Blue bloater • COPD with chronic bronchitis • Increased mucous production • Normal to decreased lung capacity • Increased residual lung volume with air trapping • Cyanosis and right heart failure • Body responds by decreasing ventilation and increasing cardiac output

  34. Blue bloater

  35. Pink puffer • COPD with severe emphysema • Pink complexion • Dyspnea • Increased residual lung capacity • Decreased elastic recoil • High tidal volume • Destruction of capillary bed • Body compensates for destruction of pulmonary capillary bed by hyperventilation • Retractions

  36. Pink puffer

  37. Effect of smoking and smoking cessation

  38. Management of COPD • Assessment, monitoring treatment of disease • Reduce risk factors • Prevent disease progression • Assess, manage anxiety and depression • Mucolytic therapy (e.g., Mucomyst) • Rehabilitation • Manage exacerbations

  39. Medications for COPD • Bronchodilators • Inhaled corticosteroids • Antibiotics • Flu vaccine annually • Pneumococcal vaccine at age 65 • Exercise training • Mucolytics and expectorants (e.g., Mucomyst, Guaifenesin)

  40. Treatment of end-stage COPD • Continuous oxygen administration—low flow • Postural drainage • Chest percussion • Controlled coughing • Tracheal suctioning

  41. Low flow oxygen in COPD • Normal stimulus to breathe is rise in CO2 level • In COPD, stimulus to breathe is a decrease in O2 level • Oxygen flow that is too high will minimize or eliminate the stimulus to breathe in a COPD patient

  42. Tuberculosis in the elderly • Elderly the most vulnerable • Drug resistant forms prevalent • Vulnerability enhanced by multiple risk factors: • Living in an institution, homeless • Exposure to drug-resistant form • Previous infection • Diabetes • Use of immunosuppresive drugs (including corticosteroids) • Malnutrition • Renal failure

  43. Treatment of tuberculosis • Isoniazid—prevent active disease once infected • Rifampin • Side effects can be significant • Interrupting treatment can create drug resistant form

  44. Lung cancer in the elderly • More common in the young-old • Initial symptoms are vague and mimic other pulmonary illnesses • Chest xray initial diagnostic test • Older, debilitated patients may not be surgical candidates • Chemotherapy • Radiation • Palliative care

  45. Respiratory infections: risk factors • History nosocomial pneumonia • COPD • Recent hospitalization, insitutionalization • Smoking • Hyperglycemia • Use of immunosuppressants and/or antibiotics and/or oxygen therapy • Recent antibiotic use • Eating dependency

  46. Pneumonia symptoms in the elderly • Cough • Fever • Sputum production • Prodromal headache, myalgia, lethargy • Changes in behavior and mental status • New onset tachycardia and tachypnea • Change in function

  47. Pneumonia

  48. Pulmonary embolism risk factors • Clotting disorders • Immobility • Dehydration • Recent surgery • Atrial fibrillation • Obesity

  49. Symptoms of pulmonary embolism • Sudden onset • Tachypnea • Dyspnea • Chest pain • Hypoxia • Hypotension • Possible shock

More Related